Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Neuralstem Approved To Commence Ischemic Stroke Trial In China 

 
Sept. 27, 2012 - (NeuralStem) - "Neuralstem, Inc. announced it has been approved to commence a clinical trial to treat motor deficits due to ischemic stroke with its spinal cord stem cells (NSI-566) at BaYi Brain Hospital, in Beijing, China, through its subsidiary, Neuralstem China (Suzhou Neuralstem Biopharmaceutical Company, Ltd.)."  Read Full Article

 

Posted on 8-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: